Stats by Source
Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)
Total = all mutations for this gene across every source.
Cell line = COSMIC Cell Lines Project + DepMap + PubMed.
Tissue = COSMIC primary-tissue (patient tumour) samples.
Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.
| Total | Cell line | Tissue | |
|---|---|---|---|
| Mutations | 628 | 92 | 532 |
| Samples | 319 | 59 | 258 |
| Peptides | 241 | 35 | 211 |
Function
LHX8 · LIM homeobox 8
The protein encoded by this gene is a member of the LIM homeobox family of proteins, which are involved in patterning and differentiation of various tissue types. These proteins contain two tandemly repeated cysteine-rich double-zinc finger motifs known as LIM domains, in addition to a DNA-binding homeodomain. This family member is a transcription factor that plays a role in tooth morphogenesis. It is also involved in oogenesis and in neuronal differentiation. This gene is a candidate gene for cleft palate, and it is also associated with odontoma formation. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jan 2012].
Isoforms & Proteins
2 transcripts · UniProt mapping is sequence-verified (AA-safe)
Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.
The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.
Counts are mutations and unique mutant peptides on each transcript.
Gene Properties
Recurrent Mutations
All 232 amino-acid changes on canonical ENST00000356261 · needle height = samples · drag the mini-map to zoom
A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).
X-axis = amino-acid position in the protein.
Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.
The most recurrent changes are labelled; hover any needle for the change, position and counts.
Mutation frequency across cancer types
% of samples with a missense/complex mutation in LHX8 · cell line vs tissue
For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in LHX8 – counted as distinct samples (a sample counts once no matter how many mutations it has).
Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.
| Cancer type | Cell lines | Tissue samples |
|---|---|---|
| T-Lymphoblastic Leukemia | 2/40 5% | 0/0 0% |
| T-Cell Non-Hodgkins Lymphoma | 1/26 4% | 0/0 0% |
| Unknown | 0/10 0% | 1/29 3% |
| Non-Small Cell Lung Carcinoma | 13/304 4% | 29/1390 2% |
| Squamous Cell Lung Carcinoma | 0/57 0% | 21/810 3% |
| Glioblastoma | 2/98 2% | 0/0 0% |
| Endometrial Carcinoma | 4/42 10% | 9/612 1% |
| Retinoblastoma | 0/27 0% | 1/30 3% |
| Other Solid Cancers | 4/94 4% | 20/1515 1% |
| Small Cell Lung Carcinoma | 0/9 0% | 11/752 1% |
| Melanoma | 7/210 3% | 23/1899 1% |
| Bladder Carcinoma | 2/58 3% | 11/956 1% |
| Gastric Carcinoma | 1/74 1% | 21/1809 1% |
| Chondrosarcoma | 0/14 0% | 1/75 1% |
| Colorectal Carcinoma | 6/143 4% | 24/3239 1% |
| Esophageal Carcinoma | 2/23 9% | 5/769 1% |
| Esophageal Squamous Cell Carcinoma | 2/51 4% | 18/2550 1% |
| Neuroendocrine Tumour | 4/154 3% | 1/577 0% |
| Cervical Carcinoma | 0/35 0% | 3/422 1% |
| Plasma Cell Myeloma | 0/44 0% | 2/305 1% |
| Ovarian Carcinoma | 1/109 1% | 5/998 0% |
| Germ Cell Tumour | 0/25 0% | 1/169 1% |
| Osteosarcoma | 1/45 2% | 0/166 0% |
| Thyroid Gland Carcinoma | 0/45 0% | 7/1592 0% |
| Biliary Tract Carcinoma | 0/54 0% | 4/950 0% |
| Other Sarcomas | 0/69 0% | 3/699 0% |
| Glioma | 0/52 0% | 7/2127 0% |
| Prostate Carcinoma | 0/13 0% | 6/2105 0% |
| Head and Neck Carcinoma | 0/85 0% | 4/1574 0% |
| B-Cell Non-Hodgkins Lymphoma | 1/88 1% | 5/2534 0% |
Mutation Distribution
Where LHX8 is mutated · all tissues, split by cell line vs tissue
How many mutations in LHX8 were found in each tissue, across the whole database.
Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.
This shows the cancer-context where this gene is recurrently altered.
GTEx Expression
Median TPM across 12 healthy tissues
Median gene expression (TPM) in normal, non-cancer human tissues from the GTEx project.
Useful for judging tumour specificity – a strong neoantigen target ideally comes from a gene with low expression in healthy tissues.
Scroll or drag the mini-axis below the chart to browse all tissues.
Mutations
All 628 mutations in LHX8
Every mutation record for this gene, across all samples and sources.
The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).
Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.
| ID | Sample | Transcript | AA Change | CDS | Type | Source | Mutant Peptide | Wild-type Peptide |
|---|